Autres langues Vincerx Pharma, Inc.

Actions

VINC

US92731L1061

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,73 ^USD	-18,59 %		-14,12 %	-38,14 %

26/04	Le rallye technologique stimule les fonds négociés en bourse et les contrats à terme sur actions avant la cloche du vendredi	MT
26/04	Vincerx Pharma fixe le prix de son offre publique d'actions et de bons de souscription	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday	26/04
Vincerx Pharma Prices Public Offering of Shares, Warrants	26/04
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants	26/04
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants	25/04
Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data	09/04
Top Premarket Decliners	09/04
Investors Eye Wednesday Inflation Data as US Futures Tread Water Tuesday Pre-Bell	09/04
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024	08/04
Vincerx Pharma, Inc. Presents Positive Preliminary Phase 1 Data for Vip236 and Updates on Pipeline Progress At the American Association for Cancer Research Annual Meeting 2024	08/04
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024	01/04
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update	29/03
Vincerx Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
North American Morning Briefing : Tech in Focus on -2-	25/03
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024	05/03
Vincerx Pharma Shares Jump After Results of Blood Cancer Treatment Trial	08/01
Top Premarket Gainers	08/01
Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma	07/01
Vincerx Pharma, Inc. Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma	07/01
Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023	10/12
Vincerx Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Vincerx Pharma, Inc.

Actions

VINC

US92731L1061

Autres langues

Filtres